Clinical trials
Completed Burkitt Lymphoma trials with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
38 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 4 |
| 2001 | 3 |
| 2002 | 3 |
| 2003 | 4 |
| 2004 | 4 |
| 2005 | 2 |
| 2006 | 3 |
| 2007 | 1 |
| 2008 | 1 |
| 2009 | 1 |
| 2010 | 2 |
| 2011 | 1 |
| 2014 | 1 |
| 2016 | 1 |
| 2019 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 38 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Fred Hutchinson Cancer Center | 6 |
| City of Hope Medical Center | 4 |
| Roswell Park Cancer Institute | 4 |
| Wake Forest University Health Sciences | 3 |
| Barbara Ann Karmanos Cancer Institute | 2 |
| National Cancer Institute (NCI) | 2 |
| Asan Medical Center | 1 |
| Assistance Publique Hopitaux De Marseille | 1 |
| Case Comprehensive Cancer Center | 1 |
| Children's Oncology Group | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Burkitt Lymphoma | 38 |
| Lymphoma, Large B-Cell, Diffuse | 34 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 34 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 31 |
| Lymphoma, Follicular | 31 |
| Lymphoma, Mantle-Cell | 31 |
| Lymphoma, B-Cell, Marginal Zone | 30 |
| Lymphoma, Large-Cell, Immunoblastic | 30 |
| Lymphoma, Non-Hodgkin | 30 |
| Multiple Myeloma | 26 |
Trials
Showing 1 to 25 of 38. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.